Literature DB >> 33883222

Species-specific valid ternary interactions of HIV-1 Env-gp120, CD4, and CCR5 as revealed by an adaptive single-amino acid substitution at the V3 loop tip.

Takaaki Koma1, Masaru Yokoyama2, Osamu Kotani2, Naoya Doi1, Nina Nakanishi1, Hayato Okubo1, Shun Adachi3, Akio Adachi3, Hironori Sato4, Masako Nomaguchi5.   

Abstract

Molecular interactions of the variable envelope gp120 subunit of HIV-1 with two cellular receptors are the first step of viral infection, thereby playing pivotal roles in determining viral infectivity and cell tropism. However, the underlying regulatory mechanisms for interactions under gp120 spontaneous variations largely remain unknown. Here we show an allosteric mechanism in which a single gp120 mutation remotely controls the ternary interactions between gp120 and its receptors for the switch of viral cell tropism. Virological analyses showed that a G310R substitution at the tip of the gp120 V3 loop selectively abolished the viral replication ability in human cells, despite evoking enhancement of viral replication in macaque cells. Molecular dynamics (MD) simulations predicted that the G310R substitution at a site away from the CD4 interaction site selectively impeded the binding ability of gp120 to human CD4. Consistently, virions with the G310R substitution exhibited a reduced binding ability to human lymphocyte cells. Furthermore, the G310R substitution influenced the gp120-CCR5 interaction in a CCR5-type dependent manner as assessed by MD simulations and an infectivity assay using exogenously expressed CCR5s. Interestingly, an I198M mutation in human CCR5 restored the infectivity of the G310R virus in human cells. Finally, MD simulation predicted amino acid interplays that physically connect the V3 loop and gp120 elements for the CD4 and CCR5 interactions. Collectively, these results suggest that the V3 loop tip is a cis-allosteric regulator that remotely controls intra- and inter-molecular interactions of HIV-1 gp120 for balancing ternary interactions with CD4 and CCR5.IMPORTANCEUnderstanding molecular bases for viral entry into cells leads to the elucidation of one of major viral survival strategies, and thus to the development of new effective antiviral measures. As experimentally shown recently, HIV-1 is highly mutable and adaptable in growth-restrictive cells such as those of macaque origin. HIV-1 initiates its infection by sequential interactions of Env-gp120 with two cell surface receptors, CD4 and CCR5. A recent epoch-making structural study has disclosed that CD4-induced conformation of gp120 is stabilized upon binding of CCR5 to the CD4-gp120 complex, whereas its biological significance remains totally unknown. Here, from a series of mutations found in our extensive studies, we identified a single-amino acid adaptive mutation at the V3 loop tip of Env-gp120 critical for its interaction with both CD4 and CCR5 in a host cell species-specific way. This remarkable finding would certainly provoke and accelerate studies to precisely clarify the HIV-1 entry mechanism.
Copyright © 2021 American Society for Microbiology.

Entities:  

Year:  2021        PMID: 33883222     DOI: 10.1128/JVI.02177-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  2 in total

1.  Unique Mode of Antiviral Action of a Marine Alkaloid against Ebola Virus and SARS-CoV-2.

Authors:  Mai Izumida; Osamu Kotani; Hideki Hayashi; Chris Smith; Tsutomu Fukuda; Koushirou Suga; Masatomo Iwao; Fumito Ishibashi; Hironori Sato; Yoshinao Kubo
Journal:  Viruses       Date:  2022-04-15       Impact factor: 5.818

2.  Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses.

Authors:  Osamu Kotani; Yasushi Suzuki; Shinji Saito; Akira Ainai; Akira Ueno; Takuya Hemmi; Kaori Sano; Koshiro Tabata; Masaru Yokoyama; Tadaki Suzuki; Hideki Hasegawa; Hironori Sato
Journal:  Viruses       Date:  2021-08-31       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.